Las Vegas, NV -- (SBWIRE) -- 11/01/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Generex Biotechnology Corporation (OTCMKTS: GNBT), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), North American Palladium Ltd (USA) (NYSEMKT: PAL), Vical Incorporated (NASDAQ:VICL)
Generex Biotechnology Corporation (OTCMKTS: GNBT) showed no change on below -normal volume of 1.29M shares. The stock settled at $0.0300 after floating in a range of $0.03 to $0.03. Its latest price has reached market capitalization of $17.41 million. Its 52-week range has been $0.02 to $0.07. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes.
Can Investors Bet on GNBT after this News update? Find out in this Research Report
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) traded down on a volume of 1.29 million, lower than its standard daily volume. Shares have dropped-6.36% to $1.62. Over the last twelve months, the stock has gained 10.2% and faced a worst price of $0.37. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.
Has CPRX Found The Bottom And Ready To Gain Momentum? Find Out Here
North American Palladium Ltd (USA) (NYSEMKT: PAL) settled -3.04% lower at $0.882 on above-normal volume of 1.27M shares during the last trading day. The stock has its 12-month high at $0.93 and 52-week low price was $0.88. It traded in a range of $0.88 to $1.98 during the last trading day. North American Palladium Ltd. (NAP) is a precious metals producer that has been operating its flagship Lac des Iles mine (LDI) located in Ontario, Canada. LDI is a primary producer of palladium.
Will PAL Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Vical Incorporated (NASDAQ:VICL) was down on low volume, trading at a volume of 1.21M shares versus its average daily volume of 1.31 million shares. At $1.25, the stock has attained market capitalization of $108.39 million. Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Why Should Investors Buy VICL After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)